Overview

Eradication of H. Pylori Infection With Moxifloxacin

Status:
Completed
Trial end date:
2022-06-08
Target enrollment:
Participant gender:
Summary
The main objective of the study is to compare the effectiveness of moxifloxacin triple therapy with levofloxacin-based sequential therapy in terms of eradication rate, safety, and patient compliance.
Phase:
Phase 3
Details
Lead Sponsor:
Iyad Naeem Muhammad, PhD
Treatments:
Amoxicillin
Levofloxacin
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
Ofloxacin
Omeprazole
Tinidazole